Nova News

Sep
2020

EYRIS AWARDED 5-YEAR CONTRACT TO DEPLOY SELENA+

Sep 2020 – EyRIS was awarded a 5-year contract for the deployment of SELENA+, an deep learning system to detect diabetic retinopathy, glaucoma and age-related macular degeneration in the Singapore Integrated Diabetic Retinopathy Program (SiDRP). This award is not only a milestone for EyRIS but also a world first in showcasing real world adoption of an artificial intelligence medical device…

Read more

Sep
2020

EYRIS CO-FOUNDERS RECOGNISED FOR CONTRIBUTION IN TECH SECTOR

Sep 2020 – We extend our heartiest congratulations to both co-founders of EyRIS, Profs Wynne Hsu and Lee Mong Li for making it onto the inaugural Singapore 100 Women in Tech (SG100WIT) List. The SGWIT100 2020 recognises the contributions of women in the tech sector and nominees are celebrated for their ability to influence, inspire and impact on community and…

Read more

Aug
2020

Building & Construction Authority (BCA), Singapore Awards Project to NOVA to Localise IFC Data Model

Aug 2020 – Singapore’s Building and Construction Authority (BCA) has awarded to novaCITYNETS, a subsidiary of Nova MSC the project to develop a Localised Industry Foundation Class (IFC) Information Model. BCA and its appointed representatives plans to adopt the internationally-accepted standard Industry Foundation Classes (IFC) as the base for the common representation for BIM model submissions by Qualified Persons (QP)…

Read more

May
2020

EYRIS SIGNS MOU WITH SINGAPORE OPTOMETRIST ASSOCIATION

Mar 2020 – Many amongst the general population are oblivious to the need for regular eye examination. To underscore this need, most of these eye conditions are silent and asymptomatic during early stages which can be vision threatening when it takes a turn for the worse. As professionals regulated by the Optometrist and Optician Board (OOB), optometrists are trained and…

Read more

Apr
2020

AI to detect papilledema from ocular fundus photographs

April 2020 – Papilledema is optic disc swelling due to high intracranial pressure possibly due to many factors such as cerebral hemorrhage, head trauma, meningitis, hydrocephalus, spinal cord lesions, impairment of cerebral sinus drainage and idiopathic intracranial hypertension (IIH). Irrespective of the cause, visual loss is the feared morbidity of papilledema, and the main mechanism of optic nerve damage is…

Read more

Mar
2020

EyRIS Founders Review Factors Influencing Performance of DLS

Mar 2020 – While the latest development in AI has been proven to be relatively accurate detecting retinal diseases, there has been little insight on what impacts clinical deployment in real-world settings. In a recent publication in NPJ Digital Medicine, EyRIS founders shared their findings from a systematic review of literature on possible factors, both image-related and technical affecting the…

Read more

Mar
2020

NOVA SECURES NATIONWIDE PROJECT TO IMPLEMENT VESALIUS IN TONGA

Mar 2020 –The Ministry of Health, Kingdom of Tonga awarded VAMED, an international end-to-end provider of solutions to healthcare facilities – the project for management, implementation and support of the nationwide Health Information System (HIS) and Electronic Medical Record (EMR). Tonga has a population of about 107,000 people living on 170 islands spread across 750,000 square kilometers in the southern…

Read more

Mar
2020

SELENA+ OBTAINS APPROVAL FOR MARKET ACCESS IN EU

9 Mar 2020 – EyRIS is pleased to announce that SELENA+, a deep learning AI system designed to detect diabetic retinopathy, glaucoma-suspect and age-related macular degeneration, jointly invented by clinicians and scientists from Singapore Eye Research Institute (SERI) and NUS School of Computing has received CE Marking certification. EyRIS is a start-up company established to commercialise SELENA+, which was trained…

Read more

Mar
2020

SELENA+ HIGHLIGHTED AS PART OF NATIONAL STRATEGY TO DELIVER QUALITY CARE

5 Mar 2020 – In a debate on Singapore Health Ministry’s budget for the year, Minister Gan Kim Yong shared the plans to leverage technologies such as artificial Intelligence and robotics to deliver quality care in the nation’s ageing and growing population. One example highlighted by Minister Gan was SELENA+, a deep learning system (DLS) to check for diabetic retinopathy,…

Read more

Jan
2020

EYRIS CO-FOUNDER DISCUSSES THE FUTURE OF AI IN OPHTHALMOLOGY

Jan 2020 – In the article published by the The Ophthalmologist – Ophthalmic Frontiers: AI, four recognized artificial intelligence and deep learning gurus discuss the use of these advanced technologies in eye care – and predict where they may take us next. We are pleased to share that Dr Daniel Ting, an EyRIS co-founder is one of the selected experts…

Read more